183 related articles for article (PubMed ID: 19598026)
21. A metabonomic approach applied to predict patients with cerebral infarction.
Jiang Z; Sun J; Liang Q; Cai Y; Li S; Huang Y; Wang Y; Luo G
Talanta; 2011 Apr; 84(2):298-304. PubMed ID: 21376948
[TBL] [Abstract][Full Text] [Related]
22. Studies of serum and feces bile acids determination by gas chromatography-mass spectrometry.
Tadano T; Kanoh M; Matsumoto M; Sakamoto K; Kamano T
Rinsho Byori; 2006 Feb; 54(2):103-10. PubMed ID: 16548228
[TBL] [Abstract][Full Text] [Related]
23. Development and validation of a gas chromatography/mass spectrometry method for the metabolic profiling of human colon tissue.
Mal M; Koh PK; Cheah PY; Chan EC
Rapid Commun Mass Spectrom; 2009 Feb; 23(4):487-94. PubMed ID: 19140133
[TBL] [Abstract][Full Text] [Related]
24. Metabolite profiling of fecal water extracts from human colorectal cancer.
Monleón D; Morales JM; Barrasa A; López JA; Vázquez C; Celda B
NMR Biomed; 2009 Apr; 22(3):342-8. PubMed ID: 19006102
[TBL] [Abstract][Full Text] [Related]
25. [Application of SELDI-TOF-MS in detection of liver metastasis from colorectal cancer].
Shi YJ; Zhao Y; Xu JM; Lai YH; Yu XZ; Zhong YS; Wei Y; Ren L; Zhu DX; Liu YK; Niu WX; Qin XY
Zhonghua Zhong Liu Za Zhi; 2008 Dec; 30(12):910-3. PubMed ID: 19173991
[TBL] [Abstract][Full Text] [Related]
26. A serum proteomic pattern for the detection of colorectal adenocarcinoma using surface enhanced laser desorption and ionization mass spectrometry.
Liu XP; Shen J; Li ZF; Yan L; Gu J
Cancer Invest; 2006 Dec; 24(8):747-53. PubMed ID: 17162557
[TBL] [Abstract][Full Text] [Related]
27. Gas chromatography/time-of-flight mass spectrometry based metabonomic approach to differentiating hypertension- and age-related metabolic variation in spontaneously hypertensive rats.
Lu Y; A J; Wang G; Hao H; Huang Q; Yan B; Zha W; Gu S; Ren H; Zhang Y; Fan X; Zhang M; Hao K
Rapid Commun Mass Spectrom; 2008 Sep; 22(18):2882-8. PubMed ID: 18720470
[TBL] [Abstract][Full Text] [Related]
28. Proteome analysis and tissue microarray for profiling protein markers associated with lymph node metastasis in colorectal cancer.
Pei H; Zhu H; Zeng S; Li Y; Yang H; Shen L; Chen J; Zeng L; Fan J; Li X; Gong Y; Shen H
J Proteome Res; 2007 Jul; 6(7):2495-501. PubMed ID: 17542627
[TBL] [Abstract][Full Text] [Related]
29. Discovery of safety biomarkers for atorvastatin in rat urine using mass spectrometry based metabolomics combined with global and targeted approach.
Kumar BS; Lee YJ; Yi HJ; Chung BC; Jung BH
Anal Chim Acta; 2010 Feb; 661(1):47-59. PubMed ID: 20113715
[TBL] [Abstract][Full Text] [Related]
30. Metabonomic profiling of diet-induced hyperlipidaemia in a rat model.
Zhang Q; Wang G; A J; Ma B; Dua Y; Zhu L; Wu D
Biomarkers; 2010 May; 15(3):205-16. PubMed ID: 20001218
[TBL] [Abstract][Full Text] [Related]
31. Serum and urinary metabonomic study of human osteosarcoma.
Zhang Z; Qiu Y; Hua Y; Wang Y; Chen T; Zhao A; Chi Y; Pan L; Hu S; Li J; Yang C; Li G; Sun W; Cai Z; Jia W
J Proteome Res; 2010 Sep; 9(9):4861-8. PubMed ID: 20690664
[TBL] [Abstract][Full Text] [Related]
32. [Establish predictive model of colorectal cancer by using surface enhanced laser desorption/ionization-time of flight-mass spectrometry].
Lai YH; Xu JM; Yu XZ; Zhong YS; Wei Y; Ren L; Zhu DX; Liu YK; Niu WX; Qin XY
Zhonghua Wai Ke Za Zhi; 2008 Jul; 46(13):995-7. PubMed ID: 19035201
[TBL] [Abstract][Full Text] [Related]
33. Dynamic metabonomic analysis of BALB/c mice with different outcomes after D-galactosamine/lipopolysaccharide-induced fulminant hepatic failure.
Feng B; Wu S; Lv S; Fang J; Liu F; Li Y; Gao Y; Yan X; Dong F; Wei L
Liver Transpl; 2008 Nov; 14(11):1620-31. PubMed ID: 18975270
[TBL] [Abstract][Full Text] [Related]
34. Analysis of urinary nucleosides as potential tumor markers in human colorectal cancer by high performance liquid chromatography/electrospray ionization tandem mass spectrometry.
Hsu WY; Chen WT; Lin WD; Tsai FJ; Tsai Y; Lin CT; Lo WY; Jeng LB; Lai CC
Clin Chim Acta; 2009 Apr; 402(1-2):31-7. PubMed ID: 19135043
[TBL] [Abstract][Full Text] [Related]
35. A pilot study of gas chromatograph/mass spectrometry-based serum metabolic profiling of colorectal cancer after operation.
Ma Y; Liu W; Peng J; Huang L; Zhang P; Zhao X; Cheng Y; Qin H
Mol Biol Rep; 2010 Mar; 37(3):1403-11. PubMed ID: 19340605
[TBL] [Abstract][Full Text] [Related]
36. Serum metabolomics as a novel diagnostic approach for gastrointestinal cancer.
Ikeda A; Nishiumi S; Shinohara M; Yoshie T; Hatano N; Okuno T; Bamba T; Fukusaki E; Takenawa T; Azuma T; Yoshida M
Biomed Chromatogr; 2012 May; 26(5):548-58. PubMed ID: 21773981
[TBL] [Abstract][Full Text] [Related]
37. Specificity of metabolic colorectal cancer biomarkers in serum through effect size.
Di Giovanni N; Meuwis MA; Louis E; Focant JF
Metabolomics; 2020 Aug; 16(8):88. PubMed ID: 32789702
[TBL] [Abstract][Full Text] [Related]
38. GC/MS analysis of the rat urine for metabonomic research.
Zhang Q; Wang G; Du Y; Zhu L; Jiye A
J Chromatogr B Analyt Technol Biomed Life Sci; 2007 Jul; 854(1-2):20-5. PubMed ID: 17526439
[TBL] [Abstract][Full Text] [Related]
39. A metabolomics study of cultivated potato (Solanum tuberosum) groups Andigena, Phureja, Stenotomum, and tuberosum using gas chromatography-mass spectrometry.
Dobson G; Shepherd T; Verrall SR; Griffiths WD; Ramsay G; McNicol JW; Davies HV; Stewart D
J Agric Food Chem; 2010 Jan; 58(2):1214-23. PubMed ID: 20028086
[TBL] [Abstract][Full Text] [Related]
40. A serum metabolomic investigation on hepatocellular carcinoma patients by chemical derivatization followed by gas chromatography/mass spectrometry.
Xue R; Lin Z; Deng C; Dong L; Liu T; Wang J; Shen X
Rapid Commun Mass Spectrom; 2008 Oct; 22(19):3061-8. PubMed ID: 18767022
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
